Krka’s €20 million investment in Pavilion 3, a 9,600 m² facility, expands microbiological laboratories, enhances digital research capabilities, and strengthens supply chain operations, ensuring higher product quality, accelerated innovation, and continued global market leadership.
The new biosimilar medicine from Lek, a Sandoz company, strengthens the well-established Sandoz immunology portfolio in Slovenia and across Europe.
Sandoz invests $90M in a cutting-edge 9,500 m² Biosimilars Development Center in Ljubljana, solidifying Slovenia’s position as a European biosimilars hub, with 200 experts advancing cell line development, biotechnological platforms, and drug formulations to expand global access to affordable, high-quality medicines.
Krka and Laurus Labs Ltd. have announced the establishment of Krka Pharma Pvt. Ltd., a joint venture based in Hyderabad, India, aiming to manufacture and expand the distribution of high-quality pharmaceutical products in India and other non-EU markets, supported by an initial capital investment of up to €50 million.
Sandoz has launched the construction of a state-of-the-art biopharmaceutical production center in Lendava, Slovenia, aiming to establish Europe’s most efficient biosimilar manufacturing facility by 2026, creating 330 jobs, advancing sustainable healthcare, and meeting the growing global demand for biologics.
Krka sets a new benchmark in sustainable logistics by launching Slovenia’s first heavy electric truck for product transport, cutting CO₂ emissions by over 40 tons annually while pioneering eco-friendly innovation in the industry.
ISDO – international business platform driving the global shift to sustainable development by promoting awareness, innovation, leadership, education, and investment. ISDO fosters international collaboration, supports sustainable technologies, and connects stakeholders to scale impactful solutions for a more sustainable future.
ISDO.ORG | All Right Reserved.
